This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of surgical disorders into clinical practice. Speakers will utilize their personal, institutional and evidence-based experience to address patient health care conditions requiring clinical and surgical treatment. Speakers will also utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of surgical disease and other aspects of surgical patients’ general health. Evidence-based data regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to surgery within the broader scope of American health care will be discussed.
There are varying degrees to individuals’ knowledge regarding clinical and surgical treatments. While individuals may be aware of varied treatment within the surgeons’ armamentarium it is beneficial to address the topics from an evidence-based approach. Learners should both have the knowledge base and be able to apply this knowledge into their practice.
Grand Rounds will address each of these shortcomings by utilizing nationally known experts in the field. Each week will provide diverse information pertaining to these issues.
Keywords: Quality and Safety, General Surgery, Surgical Oncology, Trauma, Colorectal Surgery, Vascular Surgery, Surgical Education
- Physician
- Physician Assistant
- Nurse
- Nurse Practitioner
- Fellows, Residents, Med Students
Participants who engage in this educational intervention will be able to:
- Discuss current controversies in the management of thyroid cancer
- Describe the evidence underpinning practice guidelines for the management of thyroid cancer
- Apply strategies for success in academic surgery
- Tracy Wang, MD, MPH
Leon Goldman, MD Distinguished Professor of Surgery
Professor, Department of Medicine
Affiliated faculty, Philip R. Lee Institute for Health Policy Studies
University of California, San Francisco
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Name | Company | Role |
Julie Ann Sosa, MD | GlaxoSmithKline | Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by this entity |
Novo Nordisk | Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by this entity | |
Astra Zeneca | Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by this entity | |
Eli Lilly | Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by this entity; Institutional research funding | |
Exelixis | Institutional research funding |
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.